CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 112 enrolled
Drug / intervention
Pocket colposcope/Mobile phone camera +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04421131
NCT04421131N/ACompleted

mHealth-supported Telecolposcopy for Cervical Cancer Programs in Low-resource Settings: Evaluation (mIVAA)

Duke University·interventional·Posted Jun 9, 2020·Updated Oct 17, 2022

In Brief

A clinical study evaluating Pocket colposcope/Mobile phone camera and mIVAA for Cervical Cancer. Completed, enrolled 112 participants across 1 site.

Detailed Summary

The central hypothesis is that use of mIVAA (mobile Inspección Visual con Ácido Acético - Spanish for Visual Inspection with Acetic Acid (VIA)) will increase the proportion of VIA positive women who complete follow-up clinical evaluation compared to VIA positive women in situations in which mIVAA was not used, thus potentially improving cervical cancer treatment and survival rates. The study will collect qualitative and quantitative data to examine the feasibility and preliminary impact of mIVAA on reducing attrition for follow-up clinical evaluations.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCervical Cancer
CountriesPeru

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedJun 9, 2020
Enrollment StartJan 8, 2021
Primary CompletionJun 30, 2021
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 6.1 years ago

Interventions

Pocket colposcope/Mobile phone cameradevice

The Pocket colposcope or mobile phone camera will be used to capture magnified digital images of the cervix

mIVAAother

A mobile-phone-based telemedicine platform that enables remote consultation with an expert colposcopist